CHGB is known to play a significant role in the regulation of oxidative stress pathways, and recent evidence suggests that variations in CHGB could disrupt the balance of reactive oxygen species (ROS) within neurons, contributing to neurodegeneration observed in ALS [44]. This evidence concerns the gene CHGB and amyotrophic lateral sclerosis.